Roof Eidam Maycock Peralta (REMP)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $559K | Hold |
23,207
| – | – | 0.11% | 90 |
|
|
2026
Q1 | $652K | Hold |
23,207
| – | – | 0.15% | 81 |
|
|
2025
Q4 | $578K | Sell |
23,207
-2,000
| -8% | -$50.4K | 0.13% | 81 |
|
|
2025
Q3 | $642K | Hold |
25,207
| – | – | 0.16% | 79 |
|
|
2025
Q2 | $611K | Hold |
25,207
| – | – | 0.15% | 75 |
|
|
2025
Q1 | $639K | Hold |
25,207
| – | – | 0.17% | 74 |
|
|
2024
Q4 | $669K | Sell |
25,207
-3,040
| -11% | -$82.5K | 0.17% | 73 |
|
|
2024
Q3 | $817K | Sell |
28,247
-1,748
| -6% | -$51K | 0.21% | 68 |
|
|
2024
Q2 | $839K | Hold |
29,995
| – | – | 0.23% | 65 |
|
|
2024
Q1 | $832K | Sell |
29,995
-2,321
| -7% | -$64.4K | 0.23% | 63 |
|
|
2023
Q4 | $930K | Buy |
32,316
+2
| +0% | +$60 | 0.28% | 53 |
|
|
2023
Q3 | $1.07M | Buy |
32,314
+2
| +0% | +$71 | 0.35% | 53 |
|
|
2023
Q2 | $1.19M | Buy |
32,312
+1
| +0% | +$39 | 0.4% | 48 |
|
|
2023
Q1 | $1.32M | Buy |
32,311
+2
| +0% | +$86 | 0.48% | 44 |
|
|
2022
Q4 | $1.66M | Sell |
32,309
-1,159
| -3% | -$55.6K | 0.59% | 35 |
|
|
2022
Q3 | $1.47M | Buy |
33,468
+2
| +0% | +$97 | 0.55% | 34 |
|
|
2022
Q2 | $1.75M | Buy |
33,466
+1
| +0% | +$51 | 0.65% | 28 |
|
|
2022
Q1 | $1.73M | Sell |
33,465
-259
| -0.8% | -$13.4K | 0.56% | 34 |
|
|
2021
Q4 | $1.99M | Sell |
33,724
-1,698
| -5% | -$84.1K | 0.67% | 29 |
|
|
2021
Q3 | $1.52M | Sell |
35,422
-520
| -1% | -$23K | 0.56% | 36 |
|
|
2021
Q2 | $1.41M | Hold |
35,942
| – | – | 0.53% | 39 |
|
|
2021
Q1 | $1.3M | Hold |
35,942
| – | – | 0.5% | 42 |
|
|
2020
Q4 | $1.32M | Sell |
35,942
-5,841
| -14% | -$214K | 0.51% | 36 |
|
|
2020
Q3 | $1.46M | Buy |
41,783
+274
| +0.7% | +$9.61K | 0.57% | 28 |
|
|
2020
Q2 | $1.29M | Buy |
41,509
+2,446
| +6% | +$83.1K | 0.5% | 32 |
|
|
2020
Q1 | $1.21M | Sell |
39,063
-33,289
| -46% | -$1.13M | 0.51% | 34 |
|
|
2019
Q4 | $2.69M | Buy |
72,352
+106
| +0.1% | +$3.78K | 1.04% | 20 |
|
|
2019
Q3 | $2.46M | Sell |
72,246
-9,704
| -12% | -$353K | 1% | 20 |
|
|
2019
Q2 | $3.37M | Sell |
81,950
-3,218
| -4% | -$128K | 1.38% | 19 |
|
|
2019
Q1 | $3.43M | Buy |
85,168
+25,454
| +43% | +$1.02M | 1.35% | 21 |
|
|
2018
Q4 | $2.47M | Buy |
59,714
+158
| +0.3% | +$6.56K | 1.19% | 19 |
|
|
2018
Q3 | $2.49M | Sell |
59,556
-306
| -0.5% | -$11.8K | 1.12% | 20 |
|
|
2018
Q2 | $2.06M | Buy |
59,862
+822
| +1% | +$28.1K | 0.96% | 21 |
|
|
2018
Q1 | $1.99M | Buy |
59,040
+33,428
| +131% | +$1.15M | 0.96% | 22 |
|
|
2017
Q4 | $880K | Hold |
25,612
| – | – | 0.43% | 51 |
|
|
2017
Q3 | $868K | Hold |
25,612
| – | – | 0.45% | 51 |
|
|
2017
Q2 | $816K | Hold |
25,612
| – | – | 0.42% | 51 |
|
|
2017
Q1 | $831K | Sell |
25,612
-562
| -2% | -$17.7K | 0.43% | 52 |
|
|
2016
Q4 | $807K | Sell |
26,174
-34,555
| -57% | -$1.05M | 0.42% | 44 |
|
|
2016
Q3 | $1.95M | Buy |
60,729
+38,922
| +178% | +$1.3M | 0.91% | 24 |
|
|
2016
Q2 | $728K | Sell |
21,807
-5,924
| -21% | -$189K | 0.38% | 45 |
|
|
2016
Q1 | $780K | Sell |
27,731
-5,934
| -18% | -$169K | 0.55% | 45 |
|
|
2015
Q4 | $1.03M | Sell |
33,665
-211
| -0.6% | -$6.64K | 0.82% | 29 |
|
|
2015
Q3 | $1.01M | Sell |
33,876
-105
| -0.3% | -$3.37K | 0.95% | 29 |
|
|
2015
Q2 | $1.08M | Sell |
33,981
-738
| -2% | -$24.1K | 0.89% | 31 |
|
|
2015
Q1 | $1.15M | Hold |
34,719
| – | – | 0.92% | 32 |
|
|
2014
Q4 | $1.03M | Buy |
+34,719
| New | +$996K | 0.87% | 36 |
|
Other funds holding PFE
Roof Eidam Maycock Peralta (REMP)'s PFE Position: Q2 2026 in Review
Roof Eidam Maycock Peralta (REMP) held its Pfizer (PFE) position steady in Q2 2026 at 23,207 shares worth $559K. The position accounts for 0.11% of the portfolio, ranked #90.
Roof Eidam Maycock Peralta (REMP) first reported a position in PFE in Q4 2014 and has held it in 47 quarters since. The position peaked at $3.43M in Q1 2019. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Roof Eidam Maycock Peralta (REMP) held 23,207 shares of Pfizer worth $559K as of Q2 2026.
- Roof Eidam Maycock Peralta (REMP) left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.11% of Roof Eidam Maycock Peralta (REMP)'s portfolio in Q2 2026, its #90 holding.
- Roof Eidam Maycock Peralta (REMP) first reported a position in Pfizer in Q4 2014 and has held it in 47 quarters since.
- Roof Eidam Maycock Peralta (REMP)'s Pfizer position peaked at $3.43M in Q1 2019.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Roof Eidam Maycock Peralta (REMP)'s 13F filing for Q2 2026, filed 24 Jul 2026.